-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Teladoc Health, Raises Price Target to $10

Benzinga·11/02/2026 16:59:04
Diffusion vocale
Oppenheimer analyst Michael Wiederhorn maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $7 to $10.